|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Colombo N, Preti E, Landoni F, Carinelli
S, Colombo A, Marini C and Sessa C; ESMO Guidelines Working Group.
Endometrial cancer: ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 22(Suppl 6): 35–39.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Amant F, Moerman P, Neven P, Timmerman D,
Van Limbergen E and Vergote I: Endometrial cancer. Lancet.
366:491–505. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patrelli TS, Berretta R, Rolla M, Vandi F,
Capobianco G, Gramellini D, Bacchi Modena A and Nardelli GB: Pelvic
lymphadenectomy in endometrial cancer: our current experience. Eur
J Gynaecol Oncol. 30:536–538. 2009.PubMed/NCBI
|
|
5
|
Zhang C, Wang C and Feng W:
Clinicopathological risk factors for pelvic lymph node metastasis
in clinical early-stage endometrioid endometrial adenocarcinoma.
Int J Gynecol Cancer. 22:1373–1377. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mariani A, Webb MJ, Keeney GL and Podratz
KC: Routes of lymphatic spread: a study of 112 consecutive patients
with endometrial cancer. Gynecol Oncol. 81:100–104. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morrow CP, Bundy BN, Kurman RJ, Creasman
WT, Heller P, Homesley HD and Graham JE: Relationship between
surgical-pathological risk factors and outcome in clinical stage I
and II carcinoma of the endometrium: a Gynecologic Oncology Group
study. Gynecol Oncol. 40:55–65. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berretta R, Merisio C, Piantelli G, Rolla
M, Giordano G, Melpignano M and Nardelli GB: Preoperative
transvaginal ultrasonography and intraoperative gross examination
for assessing myometrial invasion by endometrial cancer. J
Ultrasound Med. 27:349–355. 2008.
|
|
9
|
Al Kushi A, Lim P, Aquino-Parsons C and
Gilks CB: Markers of proliferative activity are predictors of
patient outcome for low-grade endometrioid adenocarcinoma but not
papillary serous carcinoma of endometrium. Mod Pathol. 15:365–371.
2002.PubMed/NCBI
|
|
10
|
Nofech-Mozes S, Ackerman I, Ghorab Z,
Ismiil N, Thomas G, Covens A and Khalifa MA: Lymphovascular
invasion is a significant predictor for distant recurrence in
patients with early-stage endometrial endometrioid adenocarcinoma.
Am J Clin Pathol. 129:912–917. 2008. View Article : Google Scholar
|
|
11
|
Merisio C, Berretta R, De Ioris A,
Pultrone DC, Rolla M, Giordano G, Tateo S and Melpignano M:
Endometrial cancer in patients with preoperative diagnosis of
atypical endometrial hyperplasia. Eur J Obstet Gynecol Reprod Biol.
122:107–111. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Di Cristofano A and Ellenson LH:
Endometrial carcinoma. Annu Rev Pathol. 2:57–85. 2007.
|
|
13
|
Gu M, Shi W, Barakat RR, Thaler HT and
Saigo PE: Peritoneal washings in endometrial carcinoma. A study of
298 patients with histopathologic correlation. Acta Cytol.
44:783–789. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Turner DA, Gershenson DM, Atkinson N,
Sneige N and Wharton AT: The prognostic significance of peritoneal
cytology for stage I endometrial cancer. Obstet Gynecol.
74:775–780. 1989.PubMed/NCBI
|
|
15
|
Hanson MB, van Nagell JR Jr, Powell DE,
Donaldson ES, Gallion H, Merhige M and Pavlik EJ: The prognostic
significance of lymph-vascular space invasion in stage I
endometrial cancer. Cancer. 55:1753–1757. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gizzo S, Di Gangi S, Bertocco A, Noventa
M, Fagherazzi S, Ancona E, Saccardi C, Patrelli TS, D’Antona D and
Nardelli GB: Levonorgestrel intrauterine system in adjuvant
tamoxifen treatment: balance of breast risks and endometrial
benefits systematic review of literature. Reprod Sci. Sep
23–2013.(Epub ahead of print).
|
|
17
|
Wright JD, Barrena Medel NI, Sehouli J,
Fujiwara K and Herzog TJ: Contemporary management of endometrial
cancer. Lancet. 379:1352–1360. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
ASTEC study group. Kitchener H, Swart AM,
Qian Q, Amos C and Parmar MK: Efficacy of systematic pelvic
lymphadenectomy in endometrial cancer (MRC ASTEC trial): a
randomised study. Lancet. 373:125–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Patrelli TS, Silini EM, Gizzo S, Berretta
R, Franchi L, Thai E, Lukanovic A, Nardelli GB and Modena AB:
Extragenital Müllerian adenosarcoma with pouch of Douglas location.
BMC Cancer. 11:1712011.
|
|
20
|
Patrelli TS, Gizzo S, Di Gangi S, Guidi G,
Rondinelli M and Nardelli GB: Cervical Mullerian adenosarcoma with
heterologous sarcomatous overgrowth: a fourth case and review of
literature. BMC Cancer. 11:2362011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Savelli L, Testa AC, Mabrouk M, Zannoni L,
Ludovisi M, Seracchioli R, Scambia G and De Iaco P: A prospective
blinded comparison of the accuracy of transvaginal sonography and
frozen section in the assessment of myometrial invasion in
endometrial cancer. Gynecol Oncol. 124:549–552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Savelli L, Ceccarini M, Ludovisi M,
Fruscella E, De Iaco PA, Salizzoni E, Mabrouk M, Manfredi R, Testa
AC and Ferrandina G: Preoperative local staging of endometrial
cancer: transvaginal sonography vs. magnetic resonance imaging.
Ultrasound Obstet Gynecol. 31:560–566. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schink JC, Rademaker AW, Miller DS and
Lurain JR: Tumor size in endometrial cancer. Cancer. 67:2791–2794.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mariani A, Webb MJ, Keeney GL, Haddock MG,
Calori G and Podratz KC: Low-risk corpus cancer: is lymphadenectomy
or radiotherapy necessary? Am J Obstet Gynecol. 182:1506–1519.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sorosky JI: Endometrial cancer. Obstet
Gynecol. 111:436–447. 2008. View Article : Google Scholar
|
|
26
|
Patrelli TS, Berretta R, Gizzo S, Pezzuto
A, Franchi L, Lukanovic A, Nardelli GB and Modena AB: CA 125 serum
values in surgically treated endometriosis patients and its
relationships with anatomic sites of endometriosis and pregnancy
rate. Fertil Steril. 95:393–396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gizzo S, Ancona E, Saccardi C, D’Antona D,
Nardelli GB and Plebani M: Could kidney glomerular filtration
impairment represent the “Achilles heel” of HE4 serum marker? A
possible further implication. Clin Chem Lab Med. 52:e45–e46.
2014.
|
|
28
|
Gusberg SB, Jones HC Jr and Tovell HM:
Selection of treatment for corpus cancer. Am J Obstet Gynecol.
80:374–380. 1960.PubMed/NCBI
|
|
29
|
Johnsson JE: Recurrences and metastases in
carcinoma of the uterine body correlated to the size and
localization of the primary tumor. Acta Obstet Gynecol Scand.
58:405–408. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schink JC, Lurain JR, Wallemark CB and
Chmiel JS: Tumor size in endometrial cancer: a prognostic factor
for lymph node metastasis. Obstet Gynecol. 70:216–219.
1987.PubMed/NCBI
|
|
31
|
Lurain JR, Rice BL, Rademaker AW,
Poggensee LE, Schink JC and Miller DS: Prognostic factors
associated with recurrence in clinical stage I adenocarcinoma of
the endometrium. Obstet Gynecol. 78:63–69. 1991.PubMed/NCBI
|
|
32
|
Milam MR, Java J, Walker JL, Metzinger DS,
Parker LP and Coleman RL; Gynecologic Oncology Group. Nodal
metastasis risk in endometrioid endometrial cancer. Obstet Gynecol.
119:286–292. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Saccardi C, Gizzo S, Patrelli TS, Ancona
E, Anis O, Di Gangi S, Vacilotto A, D’Antona D and Nardelli GB:
Endometrial surveillance in tamoxifen users: role, timing and
accuracy of hysteroscopic investigation: observational longitudinal
cohort study. Endocr Relat Cancer. 20:455–462. 2013. View Article : Google Scholar
|
